Eledon Pharmaceuticals, Inc. Increase (Decrease) in Accounts Payable
Eledon Pharmaceuticals, Inc. (ELDN) reported Increase (Decrease) in Accounts Payable of -$154.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2017-05-03
- Eledon Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2017-03-31 was -$154.00K, a 122.71% decline year-over-year.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2016-12-31 was -$456.00K.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2016-09-30 was -$960.00K.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2016-06-30 was -$40.00K.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2016 was -$778.00K, a 275.62% decline from fiscal 2015.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2015 was $443.00K, a 41.71% decline from fiscal 2014.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2014 was $760.00K.
- Eledon Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2013 was -$759.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$154.00K 10-Q · filed 2017-05-03 | -$610.00K derived: sum of 2 quarters · filed 2017-05-03 | -$1.57M derived: sum of 3 quarters · filed 2017-05-03 | -$1.61M derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-12-31 | -$456.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$1.42M derived: sum of 2 quarters · filed 2017-03-03 | -$1.46M derived: sum of 3 quarters · filed 2017-03-03 | -$778.00K 10-K · filed 2017-03-03 |
| 2016-09-30 | -$960.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.00M derived: sum of 2 quarters · filed 2016-11-03 | -$322.00K 10-Q · filed 2016-11-03 | -$766.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-06-30 | -$40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $638.00K 10-Q · filed 2016-08-04 | $194.00K derived: sum of 3 quarters · filed 2017-05-03 | $176.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-03-31 | $678.00K 10-Q · filed 2017-05-03 | $234.00K derived: sum of 2 quarters · filed 2017-05-03 | $216.00K derived: sum of 3 quarters · filed 2017-05-03 | -$1.55M derived: sum of 4 quarters · filed 2017-05-03 |
| 2015-12-31 | -$444.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$462.00K derived: sum of 2 quarters · filed 2017-03-03 | -$2.23M derived: sum of 3 quarters · filed 2017-03-03 | $443.00K 10-K · filed 2017-03-03 |
| 2015-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.78M derived: sum of 2 quarters · filed 2016-11-03 | $887.00K 10-Q · filed 2016-11-03 | -$237.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | -$1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $905.00K 10-Q · filed 2016-08-04 | -$219.00K derived: sum of 3 quarters · filed 2017-03-03 | $1.16M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | $2.67M 10-Q · filed 2016-05-10 | $1.54M derived: sum of 2 quarters · filed 2017-03-03 | $2.92M derived: sum of 3 quarters · filed 2017-03-03 | $2.63M derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $253.00K derived: sum of 2 quarters · filed 2017-03-03 | -$38.00K derived: sum of 3 quarters · filed 2017-03-03 | $760.00K 10-K · filed 2017-03-03 |
| 2014-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $1.09M derived: sum of 2 quarters · filed 2015-11-10 | $1.88M 10-Q · filed 2015-11-10 | $958.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | -$291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $507.00K 10-Q · filed 2015-08-12 | -$419.00K derived: sum of 3 quarters · filed 2016-03-10 | |
| 2014-03-31 | $798.00K 10-Q · filed 2015-05-12 | -$128.00K derived: sum of 2 quarters · filed 2016-03-10 | ||
| 2013-12-31 | -$926.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$759.00K 10-K · filed 2016-03-10 | ||
| 2013-09-30 | $167.00K 10-Q · filed 2014-11-13 | |||
| 2012-12-31 | -$119.00K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |